Christopher A. Kroeger, CEO: MapLight Therapeutics MPLT Sell · Filed 05/11

Trade details

Type: Insider sale
Amount: $423,633.6
Shares · price: 14,880 sh · $28.47 a share
Held after: 1,565,940 sh
Stock: MapLight Therapeutics MPLT
Person: Christopher A. KroegerCEO
Trade date: 26/05/07
Filed: 26/05/11
Days to filing: 4 days

Sold 0.9% of holdings

Share of holding sold: 0.9%

MapLight Therapeutics trades, last 26 weeks

What else happened in MapLight Therapeutics around then

Filed or reported within 30 days of the trade day · 04/07~06/06

Christopher A. Kroeger's recent trades

Christopher A. KroegerCEO
Planned saleMapLight Therapeutics
Planned sale
MapLight Therapeutics
MPLT
$5.8M
152,230 sh
$5.8M
Filed 07/15
Traded 07/15
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$3.2M
118,037 sh
$3.2M
Filed 05/18
Traded 05/18
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$5,574
198 sh
$5,574
Filed 05/18
Traded 05/18
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$814.1K
29,624 sh
$814.1K
Filed 05/11
Traded 05/08
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$206.4K
6,871 sh
$206.4K
Filed 05/11
Traded 05/11